XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDER'S EQUITY (DEFICIT) - USD ($)
$ in Thousands
Series A convertible preferred stock
Series A-1 convertible preferred stock
Series A-2 convertible preferred stock
Series B convertible preferred stock
Series B-1 convertible preferred stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Beginning Balances at Dec. 31, 2020           $ 1 $ 222 $ (68,220) $ (187) $ (68,184)
Beginning Balances (in shares) at Dec. 31, 2020           538,793        
Shareholders' Equity                    
Exercise of stock options             14     14
Exercise of stock options (in shares)           20,787        
Equity-based compensation             98     98
Other comprehensive loss                 (5) (5)
Net loss               223   223
Ending Balances at Mar. 31, 2021           $ 1 334 (67,997) (192) (67,854)
Ending Balances (in shares) at Mar. 31, 2021           559,580        
Beginning Balances at Dec. 31, 2020 $ 4,616 $ 5,398 $ 5,809 $ 39,547            
Beginning Balances (in shares) at Dec. 31, 2020 2,819,027 3,730,366 3,565,063 30,409,890            
Ending Balances at Mar. 31, 2021 $ 4,616 $ 5,398 $ 5,809 $ 39,547            
Ending Balances (in shares) at Mar. 31, 2021 2,819,027 3,730,366 3,565,063 30,409,890            
Beginning Balances at Dec. 31, 2020           $ 1 222 (68,220) (187) $ (68,184)
Beginning Balances (in shares) at Dec. 31, 2020           538,793        
Shareholders' Equity                    
Exercise of stock options (in shares)                   20,787
Net loss                   $ (1,267)
Ending Balances at Jun. 30, 2021           $ 1 65 (83,555) (193) (83,682)
Ending Balances (in shares) at Jun. 30, 2021           610,077        
Beginning Balances at Dec. 31, 2020 $ 4,616 $ 5,398 $ 5,809 $ 39,547            
Beginning Balances (in shares) at Dec. 31, 2020 2,819,027 3,730,366 3,565,063 30,409,890            
Ending Balances at Jun. 30, 2021 $ 4,616 $ 5,398 $ 5,809 $ 39,547 $ 29,391          
Ending Balances (in shares) at Jun. 30, 2021 2,819,027 3,730,366 3,565,063 30,409,890 10,926,089          
Beginning Balances at Mar. 31, 2021           $ 1 334 (67,997) (192) (67,854)
Beginning Balances (in shares) at Mar. 31, 2021           559,580        
Shareholders' Equity                    
Exercise of common stock warrants             34     $ 34
Exercise of common stock warrants (in shares)           50,497        
Exercise of stock options (in shares)                   0
Equity-based compensation             94     $ 94
Issuance of Series B-1 convertible preferred stock upon conversion of debt             (397) (14,068)   (14,465)
Other comprehensive loss                 (1) (1)
Net loss               (1,490)   (1,490)
Ending Balances at Jun. 30, 2021           $ 1 65 (83,555) (193) (83,682)
Ending Balances (in shares) at Jun. 30, 2021           610,077        
Beginning Balances at Mar. 31, 2021 $ 4,616 $ 5,398 $ 5,809 $ 39,547            
Beginning Balances (in shares) at Mar. 31, 2021 2,819,027 3,730,366 3,565,063 30,409,890            
Temporary equity                    
Issuance of Series B-1 Convertible Preferred Stock upon conversion of debt         $ 29,391          
Issuance of Series B-1 Convertible Preferred Stock upon conversion of debt (in shares)         10,926,089          
Ending Balances at Jun. 30, 2021 $ 4,616 $ 5,398 $ 5,809 $ 39,547 $ 29,391          
Ending Balances (in shares) at Jun. 30, 2021 2,819,027 3,730,366 3,565,063 30,409,890 10,926,089          
Beginning Balances at Dec. 31, 2021           $ 22 145,453 (94,004) (198) 51,273
Beginning Balances (in shares) at Dec. 31, 2021           22,230,032        
Shareholders' Equity                    
Exercise of stock options             303     303
Exercise of stock options (in shares)           348,552        
Equity-based compensation             1,001     1,001
Other comprehensive loss                 1 1
Net loss               (3,838)   (3,838)
Ending Balances at Mar. 31, 2022           $ 22 146,757 (97,842) (197) 48,740
Ending Balances (in shares) at Mar. 31, 2022           22,578,584        
Beginning Balances at Dec. 31, 2021           $ 22 145,453 (94,004) (198) $ 51,273
Beginning Balances (in shares) at Dec. 31, 2021           22,230,032        
Shareholders' Equity                    
Exercise of stock options (in shares)                   367,875
Net loss                   $ (9,590)
Ending Balances at Jun. 30, 2022           $ 22 147,671 (103,594) (200) 43,899
Ending Balances (in shares) at Jun. 30, 2022           22,597,907        
Beginning Balances at Mar. 31, 2022           $ 22 146,757 (97,842) (197) 48,740
Beginning Balances (in shares) at Mar. 31, 2022           22,578,584        
Shareholders' Equity                    
Exercise of stock options             22     $ 22
Exercise of stock options (in shares)           19,323       19,321
Equity-based compensation             892     $ 892
Other comprehensive loss                 (3) (3)
Net loss               (5,752)   (5,752)
Ending Balances at Jun. 30, 2022           $ 22 $ 147,671 $ (103,594) $ (200) $ 43,899
Ending Balances (in shares) at Jun. 30, 2022           22,597,907